Intensity Therapeutics, Inc.
INTS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7,067 | $2,216 | $929 | $2,590 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1,119 | $822 | $722 | $773 |
| Total Curr. Assets | $8,186 | $3,038 | $1,651 | $3,363 |
| Property Plant & Equip (Net) | $103 | $109 | $116 | $122 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1,296 | $1,296 | $1,298 | $1,298 |
| Total NC Assets | $1,399 | $1,405 | $1,414 | $1,420 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $9,585 | $4,443 | $3,065 | $4,783 |
| Liabilities | – | – | – | – |
| Payables | $1,684 | $1,193 | $1,586 | $1,219 |
| Short-Term Debt | $31 | $30 | $29 | $28 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $561 | $941 | $1,014 | $508 |
| Total Curr. Liab. | $2,276 | $2,164 | $2,629 | $1,755 |
| LT Debt | $87 | $95 | $102 | $110 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $87 | $95 | $102 | $110 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $125 | $131 | $138 |
| Total Liabilities | $2,363 | $2,259 | $2,731 | $1,865 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $5 | $3 | $2 | $2 |
| Retained Earnings | -$75,338 | -$72,667 | -$70,130 | -$66,783 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $82,555 | $74,848 | $70,462 | $69,699 |
| Total Equity | $7,222 | $2,184 | $334 | $2,918 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $9,585 | $4,443 | $3,065 | $4,783 |
| Net Debt | -$6,949 | -$2,091 | -$798 | -$2,452 |